ANTIPODES PARTNERS Ltd Q3 2025 Filing

Filed November 10, 2025

Portfolio Value

$4.5T

Holdings

115

Report Date

Q3 2025

Filing Type

13F-HR

All Holdings (115 positions)

#StockSharesValue% PortfolioType
101
NUVLNuvalent Inc
391$33.8M0.00%
102
SYKStryker Corp
91$33.6M0.00%
103
APGEApogee Therapeutics Inc
843$33.5M0.00%
104
JANXJanux Therapeutics Inc
1,344$32.9M0.00%
105
WAYWaystar Holding Corp
823$31.2M0.00%
106
AM6Amicus Therapeutics Inc
3,926$30.9M0.00%
107
DHRDanaher Corp
137$27.2M0.00%
108
WATWaters Corp
88$26.4M0.00%
109
SGMTSagimet Biosciences Inc
3,176$21.8M0.00%
110
IDYAIdeaya Biosciences Inc
770$21.0M0.00%
111
HUMAHumacyte Inc
8,125$14.1M0.00%
112
ARRYArray Technologies Inc
1,715$14.0M0.00%
113
DAWNDay One Biopharmaceuticals Inc
1,731$12.2M0.00%
114
SQMSociedad Quimica y Minera de C
182$7.8M0.00%
115
SHLSShoals Technologies Group Inc
978$7.2M0.00%
PreviousPage 2 of 2